Kim Choy Yap

CIK: 0002081554

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CYCC

Cyclacel Pharmaceuticals, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BGMS
Bio Green Med Solution, Inc.
Nov 5, 2025
Other(J)
Direct
467.5K shares-
BGMS
Bio Green Med Solution, Inc.
Nov 5, 2025
Sale(S)
Direct
28.5K shares at avg. $1.70$49K
BGMS
Bio Green Med Solution, Inc.
Oct 30, 2025
Sale(S)
Direct
112.3K shares at avg. $1.81$203K
BGMS
Bio Green Med Solution, Inc.
Oct 29, 2025
Sale(S)
Direct
110.7K shares at avg. $1.83$203K
BGMS
Bio Green Med Solution, Inc.
Oct 28, 2025
Sale(S)
Direct
13.1K shares at avg. $1.83$24K
BGMS
Bio Green Med Solution, Inc.
Oct 27, 2025
Sale(S)
Direct
120.3K shares at avg. $2.12$255K
BGMS
Bio Green Med Solution, Inc.
Oct 24, 2025
Sale(S)
Direct
19.6K shares at avg. $1.90$37K
CYCC
Cyclacel Pharmaceuticals, Inc.
Sep 4, 2025
Other(J)
Direct
186.5K shares-

		Type	Shares	Price		Ownership
Nov 5, 2025	BGMS Bio Green Med Solution, Inc.	Other(J)	467,535	-	-	Direct
Nov 5, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	28,540	$1.70	$48,518	Direct
Oct 30, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	112,260	$1.81	$202,854	Direct
Oct 29, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	110,749	$1.83	$203,114	Direct
Oct 28, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	13,111	$1.83	$23,967	Direct
Oct 27, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	120,250	$2.12	$254,690	Direct
Oct 24, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	19,595	$1.90	$37,270	Direct
Sep 4, 2025	CYCC Cyclacel Pharmaceuticals, Inc.	Other(J)	186,465	-	-	Direct

1-8 of 8 transactions

About Yap Kim Choy

Yap Kim Choy (SEC CIK 0002081554) files insider reports with the SEC as 10% Owner of Cyclacel Pharmaceuticals, Inc. (CYCC).

Signal8 holds 8 ownership filings by Yap Kim Choy (1 Form 3, 7 Form 4), filed between Sep 2, 2025 and Nov 5, 2025. Those filings report 8 transactions, from Sep 4, 2025 to Nov 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Yap Kim Choy's filings is in PUCHONG, N8.

Recent filings by Yap Kim Choy

Nov 5, 2025: Other transaction of BGMS shares (Form 4, code J).
Nov 5, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 30, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 29, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 28, 2025: Open-market sale of BGMS shares (Form 4, code S).

Other insiders filing for Cyclacel Pharmaceuticals, Inc. (CYCC)

Kiu Cu Seng, CFO and Secretary
Doris Wong Sing Ee, Chief Executive Officer
Ong Yee Lung, 10% Owner
Kua Khai Loon, 10% Owner
Lazar David E., Interim CEO
Tan Kok Hui, 10% Owner

How to read Form 4 transaction codes